These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3682 related items for PubMed ID: 12208749

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.
    Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN.
    Proc Natl Acad Sci U S A; 2000 Sep 26; 97(20):10972-7. PubMed ID: 10995484
    [Abstract] [Full Text] [Related]

  • 23. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
    Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M.
    J Endocrinol; 2008 Feb 26; 196(2):399-412. PubMed ID: 18252963
    [Abstract] [Full Text] [Related]

  • 24. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr 26; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA, Thompson LU.
    Breast Cancer Res Treat; 2003 Oct 26; 81(3):209-21. PubMed ID: 14620916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I.
    Mol Cancer; 2006 Nov 05; 5():57. PubMed ID: 17083744
    [Abstract] [Full Text] [Related]

  • 32. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
    Tonetti DA, Rubenstein R, DeLeon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A, Craig Jordan V.
    J Steroid Biochem Mol Biol; 2003 Oct 05; 87(1):47-55. PubMed ID: 14630090
    [Abstract] [Full Text] [Related]

  • 33. Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.
    Fortunati N, Bertino S, Costantino L, De Bortoli M, Compagnone A, Bandino A, Catalano MG, Boccuzzi G.
    Mol Cell Endocrinol; 2010 Jan 15; 314(1):17-22. PubMed ID: 19772891
    [Abstract] [Full Text] [Related]

  • 34. Regulation of prothymosin alpha by estrogen receptor alpha: molecular mechanisms and relevance in estrogen-mediated breast cell growth.
    Bianco NR, Montano MM.
    Oncogene; 2002 Aug 08; 21(34):5233-44. PubMed ID: 12149645
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K, Banerjee S, Saxena N, Banerjee SK.
    Int J Oncol; 2003 Mar 08; 22(3):609-14. PubMed ID: 12579315
    [Abstract] [Full Text] [Related]

  • 37. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
    Ni YD, Hong WJ, Zhou YC, Grossmann R, Zhao RQ.
    Steroids; 2010 Mar 08; 75(3):245-51. PubMed ID: 20043933
    [Abstract] [Full Text] [Related]

  • 38. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC.
    Cancer Res; 2005 Apr 15; 65(8):3487-92. PubMed ID: 15833885
    [Abstract] [Full Text] [Related]

  • 39. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O, Yamagishi T, Hanada K, Kawashima H.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):705-11. PubMed ID: 11726205
    [Abstract] [Full Text] [Related]

  • 40. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G.
    Cancer Res; 2002 Aug 01; 62(15):4316-24. PubMed ID: 12154035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 185.